Carboplatin Kabi is a platinum based antineoplastic drug used in chemotherapy.

ATC-Code: L01XA02


Strength is denoted by disposable cap color.

  • Carboplatin Kabi 50 mg/5 ml
  • Carboplatin Kabi 150 mg/15 ml
  • Carboplatin Kabi 450 mg/45 ml
  • Carboplatin Kabi 600 mg/60 ml


​Carboplatin Kabi is indicated for treatment of advanced ovarian carcinoma of epithelial origin in first & second line therapy after other treatments have failed and small cell carcinoma of the lung.

Product Information

​Please note that this product may not be available in all countries due to different registration status.

Additionally, approved indications, contraindications, side effects, warnings and all over product characteristics may differ between countries. Therefore, always the text of the nationally registered and approved product information is binding! Furthermore, country specific regulatory considerations affect the information we can provide on our products.

If you require any information please contact your local organization.